AstraZeneca’s Imfinzi shows promise in treating aggressive lung cancer
- 05-Apr-2024
AstraZeneca (AZN.L), opens new tab said on Friday its blockbuster cancer drug Imfinzi helped improve overall and progression-free survival in patients with limited-stage small cell lung cancer. The drug demonstrated “statistically significant and clinically meaningful improvement” in the dual primary goals of overall survival and progression-free survival in patients for whom the disease had not […]
Imfinzi and Imjudo: US approves lung cancer drugs
- 11-Nov-2022
AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV non-small cell lung cancer. The approval by the Food and Drug Administration (FDA) was based on the results from the POSEIDON Phase III trial. Patients treated with a limited […]
China approves AstraZeneca drug for lung cancer
- 19-Jul-2021
China has approved AstraZeneca’s drug Imfinzi to treat an aggressive type of lung cancer in adults, the company said on Monday, in a boost to its efforts to tackle the disease. China’s National Medical Products Administration has okayed use of the drug with chemotherapy in adults with extensive-stage small cell lung cancer (SCLC), the Anglo-Swedish […]